Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Total revenue | 0.13%124.04M | 5.56%123.87M | 75.16%117.34M | 3,857.36%66.99M | 1,266.85%1.69M | 123.85K |
| Operating revenue | 0.13%124.04M | 5.56%123.87M | 75.16%117.34M | 3,857.36%66.99M | 1,266.85%1.69M | --123.85K |
| Cost of revenue | 0.71%90.29M | 16.73%89.65M | 84.78%76.8M | 4,969.39%41.56M | 11,506.91%819.91K | 7.06K |
| Gross profit | -1.37%33.75M | -15.59%34.22M | 59.44%40.54M | 2,812.87%25.43M | 647.46%872.93K | 116.79K |
| Operating expense | -2.88%28.51M | 41.96%29.35M | 27.73%20.68M | 94.13%16.19M | 94.72%8.34M | 4.28M |
| Selling and administrative expenses | -7.29%18.84M | 36.24%20.32M | 1.76%14.92M | 226.42%14.66M | 16.75%4.49M | --3.85M |
| -Selling and marketing expense | -30.77%1.91M | 409.08%2.77M | 2.73%543.14K | 85.10%528.71K | --285.63K | ---- |
| -General and administrative expense | -3.60%16.93M | 22.15%17.56M | 1.73%14.37M | 236.02%14.13M | 9.32%4.21M | --3.85M |
| Depreciation amortization depletion | 38.99%2.28M | 66.13%1.64M | 44.64%988.36K | -80.05%683.31K | 8,252.62%3.43M | --41.01K |
| -Depreciation and amortization | 38.99%2.28M | 66.13%1.64M | 44.64%988.36K | -80.05%683.31K | 8,252.62%3.43M | --41.01K |
| Other operating expenses | -0.02%7.39M | 54.82%7.39M | 463.96%4.77M | 100.08%846.08K | 7.09%422.87K | --394.86K |
| Operating profit | 7.70%5.24M | -75.50%4.87M | 115.01%19.86M | 223.75%9.24M | -79.23%-7.47M | -4.17M |
| Net non-operating interest income (expenses) | -117.27%-820.11K | -446.83%-377.46K | 125.17%108.83K | -74.63%-432.37K | -239.45%-247.6K | -72.94K |
| Non-operating interest income | -35.58%431.53K | 100.38%669.87K | 3,587.09%334.31K | -80.53%9.07K | -64.78%46.56K | --132.2K |
| Non-operating interest expense | -18.24%856.29K | 364.50%1.05M | -48.92%225.48K | 50.07%441.44K | 43.40%294.16K | --205.14K |
| Total other finance cost | --395.34K | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 280.27%283.68K | -8.70%74.6K | -67.96%81.71K | 208.95%255K | -60.30%82.54K | 207.88K |
| Other non-operating income (expenses) | 221.47%239.82K | -8.70%74.6K | -67.96%81.71K | 208.95%255K | -60.30%82.54K | --207.88K |
| Income before tax | 3.09%4.71M | -77.24%4.56M | 105.80%20.05M | 331.69%9.74M | -5.42%-4.21M | -3.99M |
| Income tax | 25.06%1.64M | -79.16%1.31M | 68.91%6.3M | 3.73M | 0 | 0 |
| Earnings from equity interest net of tax | ||||||
| Net income | -5.79%3.06M | -76.36%3.25M | 128.70%13.75M | 242.96%6.01M | -5.42%-4.21M | -3.99M |
| Net income continuous operations | -5.79%3.06M | -76.36%3.25M | 128.70%13.75M | 242.96%6.01M | -5.42%-4.21M | ---3.99M |
| Noncontrolling interests | -0.11%-262.47K | -343.83%-262.18K | -63.97%-59.07K | 77.00%-36.03K | -198.56%-156.64K | -52.47K |
| Net income attributable to the company | -5.35%3.32M | -74.57%3.51M | 128.31%13.81M | 249.38%6.05M | -2.84%-4.05M | -3.94M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | -5.35%3.32M | -74.57%3.51M | 128.31%13.81M | 249.38%6.05M | -2.84%-4.05M | -3.94M |
| Diluted earnings per share | -11.29%0.0055 | -75.10%0.0062 | 99.20%0.0249 | 139.68%0.0125 | 26.57%-0.0315 | -0.0429 |
| Basic earnings per share | -11.29%0.0055 | -74.38%0.0062 | 95.16%0.0242 | 139.37%0.0124 | 26.57%-0.0315 | -0.0429 |
| Dividend per share | 0 | 0.00%0.01 | 0.01 | |||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |